Corient Capital Partners, LLC Edwards Lifesciences Corp Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 11,263 shares of EW stock, worth $793,816. This represents 0.08% of its overall portfolio holdings.

Number of Shares

11,263

Previous 10,849 3.82%

Holding current value

$793,816

Previous $1.03 Million 3.78%

% of portfolio

0.08%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $34,101 - $44,418	414 Added 3.82%	11,263 $1.07 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $86,500 - $128,270	1,000 Added 10.15%	10,849 $1.03 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $66,987 - $84,319	657 Added 7.15%	9,849 $1.16 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $822,878 - $1.01 Million	-7,736 Reduced 45.7%	9,192 $1.19 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $198,101 - $236,293	-1,925 Reduced 10.21%	16,928 $1.92 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $282,289 - $352,726	3,367 Added 21.74%	18,853 $1.95 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $665,868 - $767,340	8,463 Added 120.5%	15,486 $1.3 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $15,628 - $19,888	218 Added 3.2%	7,023 $641,000
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $10,616 - $13,815	-158 Reduced 2.27%	6,805 $543,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $279,989 - $374,438	4,866 Added 232.05%	6,963 $481,000
Q1 2020 May 06, 2020	SELL	$52.41 - $81.0 $13,259 - $20,493	-253 Reduced 10.77%	2,097 $395,000
Q4 2019 Feb 04, 2020	BUY	$71.7 - $82.09 $7,815 - $8,947	109 Added 4.86%	2,350 $549,000
Q3 2019 Nov 06, 2019	BUY	$61.55 - $75.43 $32,313 - $39,600	525 Added 30.59%	2,241 $492,000
Q2 2019 Aug 08, 2019	BUY	$55.74 - $64.41 $6,577 - $7,600	118 Added 7.38%	1,716 $317,000
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $76,528 - $102,351	1,598 New	1,598 $306,000

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Edwards Lifesciences Corp Transaction History